Technological advances in the serological diagnosis of Chagas disease in dogs and cats: a systematic review
- PMID: 36167575
- PMCID: PMC9516836
- DOI: 10.1186/s13071-022-05476-4
Technological advances in the serological diagnosis of Chagas disease in dogs and cats: a systematic review
Abstract
Background: Chagas disease (CD) is caused by Trypanosoma cruzi, which is transmitted mainly through the feces/urine of infected triatomine bugs. The acute phase lasts 2-3 months and is characterized by high parasitemia and nonspecific symptoms, whereas the lifelong chronic phase features symptoms affecting the heart and/or digestive tract occurring in 30-40% of infected individuals. As in humans, cardiac abnormalities are observed in T. cruzi-infected dogs and cats. We reviewed the technological advances in the serological diagnosis of CD in dogs and cats.
Methods: A review of the published literature during the last 54 years (1968-2022) on the epidemiology, clinical features, diagnosis, treatment and prevention of CD in dogs and cats was conducted.
Results: Using predefined eligibility criteria for a search of the published literature, we retrieved and screened 436 publications. Of these, 84 original studies were considered for inclusion in this review. Dogs and cats are considered as sentinels, potentially indicating an active T. cruzi transmission and thus the risk for human infection. Although dogs and cats are reputed to be important for maintaining the T. cruzi domestic transmission cycle, there are no commercial tests to detect past or active infections in these animals. Most published research on CD in dogs and cats have used in-house serological tests prepared with native and/or full-length recombinant antigens, resulting in variable diagnostic performance. In recent years, chimeric antigens have been used to improve the diagnosis of chronic CD in humans with encouraging results. Some of them have high performance values (> 95%) and extremely low cross-reactivity rates for Leishmania spp., especially the antigens IBMP-8.1 to IBMP-8.4. The diagnostic performance of IBMP antigens was also investigated in dogs, showing high diagnostic performance with negligible cross-reactivity with anti-Leishmania infantum antibodies.
Conclusions: The development of a commercial immunodiagnostic tool to identify past or active T. cruzi infections in dogs and cats is urgently needed. The use of chimeric recombinant T. cruzi antigens may help to fill this gap and is discussed in this review.
Keywords: Cats; Diagnosis; Dogs; Epidemiology; Serology; Trypanosoma cruzi.
© 2022. The Author(s).
Conflict of interest statement
Filipe Dantas-Torres is Editor-in-Chief of Parasites & Vectors, but the peer review process and final decision was handled independently by the Professor Anna Bajer, Subject Editor of the section Protozoa and protozoan diseases.
Figures
Similar articles
-
Chagas Disease: A Silent Threat for Dogs and Humans.Int J Mol Sci. 2024 Mar 29;25(7):3840. doi: 10.3390/ijms25073840. Int J Mol Sci. 2024. PMID: 38612650 Free PMC article. Review.
-
Evaluation of chimeric recombinant antigens for the serodiagnosis of Trypanosoma cruzi in dogs: a promising tool for Chagas disease surveillance.Parasit Vectors. 2024 Jul 15;17(1):305. doi: 10.1186/s13071-024-06376-5. Parasit Vectors. 2024. PMID: 39010122 Free PMC article.
-
Performance of recombinant chimeric proteins in the serological diagnosis of Trypanosoma cruzi infection in dogs.PLoS Negl Trop Dis. 2019 Jun 26;13(6):e0007545. doi: 10.1371/journal.pntd.0007545. eCollection 2019 Jun. PLoS Negl Trop Dis. 2019. PMID: 31242195 Free PMC article.
-
Chagas Immunochromatographic Rapid Test in the Serological Diagnosis of Trypanosoma cruzi Infection in Wild and Domestic Canids.Front Cell Infect Microbiol. 2022 Feb 22;12:835383. doi: 10.3389/fcimb.2022.835383. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35273924 Free PMC article.
-
Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.PLoS One. 2015 Oct 5;10(10):e0139363. doi: 10.1371/journal.pone.0139363. eCollection 2015. PLoS One. 2015. PMID: 26436678 Free PMC article. Review.
Cited by
-
Chagas Disease: A Silent Threat for Dogs and Humans.Int J Mol Sci. 2024 Mar 29;25(7):3840. doi: 10.3390/ijms25073840. Int J Mol Sci. 2024. PMID: 38612650 Free PMC article. Review.
-
Seroepidemiological Survey of Chronic Chagas Disease in a Rural Community in Southern Bahia, Brazil, Using Recombinant Chimeric Antigens.Pathogens. 2023 Oct 7;12(10):1222. doi: 10.3390/pathogens12101222. Pathogens. 2023. PMID: 37887738 Free PMC article.
-
Evaluation of chimeric recombinant antigens for the serodiagnosis of Trypanosoma cruzi in dogs: a promising tool for Chagas disease surveillance.Parasit Vectors. 2024 Jul 15;17(1):305. doi: 10.1186/s13071-024-06376-5. Parasit Vectors. 2024. PMID: 39010122 Free PMC article.
-
IgG Isotypes Targeting a Recombinant Chimeric Protein of Trypanosoma cruzi in Different Clinical Presentations of Chronic Chagas Disease.Am J Trop Med Hyg. 2024 Feb 27;110(4):669-676. doi: 10.4269/ajtmh.23-0652. Print 2024 Apr 3. Am J Trop Med Hyg. 2024. PMID: 38412539 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous